Lab business > Market analysis

The politics of health: how elections will impact on life sciences

06 August, 2024 by Ivor Campbell*

With elections this year in the US, the UK and India — all major players in the life sciences industry — what changes and benefits can we expect to see?


Could Amazon or Google hold the key to the future of public health diagnostics?

04 June, 2024 by Ivor Campbell*

Collaboration, transparency and a shared commitment to sustainability could pave the path towards a future where a universal reader revolutionises diagnostic testing.


Does China's leading place in the global medtech market reflect the reality?

08 May, 2024 by Ivor Campbell*

To many healthcare buyers in the US, Europe, South-East Asia, Africa and South America, China remains an enigmatic and largely unexplored entity.


Clinical Trial Transformation: Recent Changes and Future Predictions

01 April, 2024

Accelerated by the COVID-19 pandemic, we have seen a shift in clinical trials, with changes to the way they are conducted, regulated and perceived.


Animal research survey suggests more transparency needed

02 August, 2022

While the majority of Australians support the use of animals in research, this support is highly conditional and most agree there needs to be more transparency.


Automation of laboratory accessories opens up new vistas

26 October, 2020 by Smita Deshmukh*

Laboratory accessories have enabled great strides for the life sciences industry, including new developments in drug discovery.


Logistics requirements for a COVID-19 vaccine

08 September, 2020

DHL has published a white paper on delivering stable logistics for vaccines and medical goods during COVID-19 and future health crises.


Aus STEM workforce feels the blow of COVID‑19

25 May, 2020 by Lauren Davis

Australia's research workforce will be severely impacted by the COVID-19 pandemic for an extended period, according to a newly published report.


How to make open innovation work for your company

06 May, 2019

According to Afnan Zafar, collaboration in the field of product development must follow a strict set of rules if firms really want to benefit from open innovation and boost their performance.


Smaller teams produce more innovative research, study finds

14 February, 2019

A new analysis of more than 65 million papers, patents and software projects found that smaller teams produce much more disruptive and innovative research than larger teams.


Australian R&D investment drooping

19 October, 2018

The Australian Government's Science, Research and Innovation (SRI) Budget Tables show that overall investment in research and development is continuing to fall.


UK–US trade deal could threaten the NHS, researchers say

13 July, 2018

The USA's targeting of so-called 'foreign free-riding' in trade deals could lead to a poor deal on pharmaceuticals for the UK post-Brexit.


Gene therapies may not be commercially viable: GlobalData

27 June, 2018

Gene therapies stand to benefit patients immensely, but there are questions about their commercial viability for pharmaceutical companies.


Report: Synthetic biology could be misused to create weapons

21 June, 2018

Although some malicious applications of synthetic biology may not seem plausible right now, they could become achievable with future advances.


Women in STEM: pay improving but opportunities lacking

08 March, 2018

A national survey has revealed that female scientists are not getting the same opportunities for promotion or seniority as their male peers with similar qualifications and experience.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd